Ftse Mib
35.355,87
0,58%
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
NASDAQ
16.742,39
1,40%
Bitcoin
66.132,26
7,45%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Heart Test Laboratories Inc (HSCS) Heart Test Laboratories Inc (HSCS) Notizie

Heart Test Laboratories Inc

HSCS
0,088
0,0089 (11,25%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:35:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202415:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
02/4/202422:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/3/202414:00GLOBEHeartSciences Announces Podium Presentation at World..
14/3/202421:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/3/202414:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/3/202415:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
05/3/202422:55EDGAR2Form S-1 - General form for registration of securities under..
26/2/202423:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202415:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
15/2/202422:30EDGAR2Form 8-K - Current report
12/2/202415:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/2/202415:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
31/1/202415:00EDGAR2Form 8-K - Current report
25/1/202414:59EDGAR2Form 8-K - Current report
18/1/202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202414:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202414:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
18/1/202413:55EDGAR2Form 8-K - Current report
03/1/202422:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
14/12/202322:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
14/12/202322:07EDGAR2Form 8-K - Current report
14/12/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/12/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202314:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/12/202323:14EDGAR2Form DEF 14A - Other definitive proxy statements
07/12/202323:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
06/12/202315:21EDGAR2Form 8-K - Current report
05/12/202314:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
28/11/202323:26EDGAR2Form PRE 14A - Other preliminary proxy statements
27/11/202322:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202314:30EDGAR2Form 8-K - Current report
21/11/202314:30EDGAR2Form 8-K - Current report
20/11/202314:00GLOBEHeartSciences Announces Closing of License Agreements with..
17/11/202322:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202322:26EDGAR2Form 8-K - Current report
13/11/202314:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202315:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
14/10/202303:36EDGAR2Form S-1/A - General form for registration of securities..
04/10/202323:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202314:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/9/202314:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
22/9/202322:16EDGAR2Form 8-K - Current report
21/9/202314:00EDGAR2Form 8-K - Current report
21/9/202314:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
18/9/202312:09EDGAR2Form S-3 - Registration statement under Securities Act of..
14/9/202322:24EDGAR2Form 8-K - Current report
14/9/202322:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
14/9/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/9/202322:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
11/9/202322:15GLOBEHeartSciences Named Electrocardiography Advancement..
Apertura: 0,083 Min: 0,0735 Max: 0,0899
Chiusura: 0,0791

La tua Cronologia

NASDAQ
HSCS
Heart Test Laboratories
HUOB
ENGBTC
Enigma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network